Loss of Microbiota-Mediated Colonization Resistance toClostridium difficileInfection With Oral Vancomycin Compared With Metronidazole-Reference-Cited by-同舟云学术

Loss of Microbiota-Mediated Colonization Resistance toClostridium difficileInfection With Oral Vancomycin Compared With Metronidazole

Published:2015-04-28 Issue:10 Volume:212 Page:1656-1665
ISSN:0022-1899
Container-title:Journal of Infectious Diseases
language:en
Short-container-title:J Infect Dis.

Author:

Lewis Brittany B.,Buffie Charlie G.,Carter Rebecca A.,Leiner Ingrid,Toussaint Nora C.,Miller Liza C.,Gobourne Asia,Ling Lilan,Pamer Eric G.

Funder

National Institutes of Health (NIH)

the Tow Foundation

a Medical Scientist Training Program

the National Institute of General Medical Sciences

NIH

the Weill Cornell/Rockefeller/Sloan Kettering Tri-institutional MD-PhD Program

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/212/10/1656/16866635/jiv256.pdf

Reference32 articles.

1. Historical Perspectives on Studies ofClostridium difficileandC. difficileInfection

2. An Epidemic, Toxin Gene–Variant Strain ofClostridium difficile

3. Emergence and global spread of epidemic healthcare-associated Clostridium difficile

4. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States. http://www.cdc.gov/drugresistance/threat-report-2013/ . Accessed 16 January 2015.

5. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liquid crystal nanoparticles for oral combination antibiotic therapies: A strategy towards protecting commensal gut bacteria during treatment;Journal of Colloid and Interface Science;2025-01

2. Macleaya cordata extract exhibits some potential as a surrogate antibiotic by improving gastrointestinal epithelial status and humoral response in goats;Animal Nutrition;2024-09

3. Current View on Major Natural Compounds Endowed with Antibacterial and Antiviral Effects;Antibiotics;2024-06-28

4. Lyophilized fecal microbiome transfer for primary Clostridioides difficile infection: a multicenter randomized controlled trial (DONATE Study);Open Research Europe;2024-03-26

5. In vivo evaluation of Clostridioides difficile enoyl-ACP reductase II (FabK) inhibition by phenylimidazole unveils a promising narrow-spectrum antimicrobial strategy;Antimicrobial Agents and Chemotherapy;2024-03-06